The emerging field of postbiotics—metabolites produced by beneficial bacteria rather than live organisms themselves—has reached a compelling milestone with evidence linking specific bacterial compounds to measurable improvements in muscle function. This development represents a significant evolution beyond traditional probiotics, offering potentially more stable and standardized interventions for healthy aging.
This 12-week controlled trial demonstrated that daily consumption of postbiotics derived from Lentilactobacillus kefiri DH5, combined with melon extract and whey protein, produced a statistically significant increase in dominant-hand grip strength among healthy adults. The intervention also elevated plasma irisin—a muscle-derived hormone associated with metabolic health—while reducing inflammatory marker IL-1β. Notably, the bacterial fermentation process appeared crucial, as the combination specifically enhanced gut populations of Bifidobacterium adolescentis and several other beneficial species while reducing potentially problematic strains.
The most intriguing finding was the positive correlation between Faecalibacterium prausnitzii abundance and irisin levels, suggesting a direct mechanistic pathway between gut bacteria and muscle-signaling hormones. This connection provides biological plausibility for the gut-muscle axis that researchers have theorized but struggled to demonstrate clinically. However, the study's 12-week duration and focus on grip strength alone limit broader conclusions about functional muscle outcomes or long-term benefits. The lack of effect on lean mass or non-dominant hand strength also raises questions about the intervention's practical significance. While promising as proof-of-concept for targeted postbiotic applications, this represents an incremental advance requiring replication across diverse populations and longer timeframes.